Hines CKD, Gutiérrez NM, Tinoco CV

Language: Spanish
References: 18
Page: 1-10
PDF size: 174.87 Kb.

ABSTRACT

Myasthenia Gravis is an autoimmune disease that affects the neuromuscular junction, by blocking it functionally, by producing antibodies against nicotinic receptors. It presents with symptoms of fatigue in different muscle groups, which can affect speech, swallowing and breathing. This pathology is treated with anticholinesterase drugs, corticosteroids and/or thymectomy. Patients with myasthenia gravis have a higher risk of perioperative complications than the general population. Due to this, special care must be taken in the perioperative period. Respiratory failure is a life-threatening complication, so the risks of respiratory muscle weakness should be minimized. the patient is aware of possible complications

REFERENCES

1. Guilmette J, Sadow PM. Parathyroid Pathology. Surg Pathol Clin. 2019; 12 (4): 1007-1019. https://doi.org/10.1016/j.path.2019.08.006

2. Reid LM, Kamani D, Randoplh GW. Management of Parathyroid Disorders. Cummings Otolaryngology Head and Neck Surgery. 7ma edición. Filadelfia, Pensilvania: Elsevier: 2020. 1899-1916.

3. Demir AD. A review of parathyroid mass and patients with nonspecific complaints. J Int Med Res. 2020; 0 (0): 1-6. https://doi.org/10.1177/0300060519827169

4. Jason DS, Balentine CJ. Intraoperative Decision Making in Parathyroid Surgery. Surg Clin North Am. 2019; 99 (4): 681-691. https://doi.org/10.1016/j.suc.2019.04.008

5. Baj J, Sitarz R, Łokaj M, Forma A, Czeczelewski M, Maani A, et al. Preoperative and Intraoperative Methods of Parathyroid Gland Localization and the Diagnosis of Parathyroid Adenomas. Molecules [Internet]. MDPI AG; 2020 Apr 9;25(7):1724. Available from: http://dx.doi.org/10.3390/molecules25071724

6. Goltzman D. Phisiology of Parathyroid Hormon. Endocrinol Metab Clin North Am. 2018; 47 (4): 743-758. https://doi.org/10.1016/j.ecl.2018.07.003

7. Bringhurst FR. Demay MB, Kronenberg HM. Hormones and Disorders of Mineral Metabolism. Williams Textbook of Endocrinology. 14va edición. Filadelfia, Pensilvania: Elsevier; 2020. 1196-1255.

8. Rao SD. Epidemiology of Parathyroid disorders. Best Pract Clin Endocrinol Metab. 2018; 32 (6): 773-780. https://doi.org/10.1016/j.beem.2018.12.003

9. Kuzminski S, Sosa JA, Hoang JK. Update in Parathyroid Imaging. Magn Reson Imaging Clin N Am. 2018; 26 (1): 151-166. https://doi.org/10.1016/j.mric.2017.08.009

10. Shoback DM, Schafer AL, Bikle DD. Metabolic Bone Disease. Greenspan's Basic and Clinical Endocrinology. 10ma edición. Nueva York, Estados Unidos: McGraw- Hill: 2017. 239-297.

11. Sethi N, England RJ. Parathyroid surgery:from inception to the modern day. Br J Hosp Med (Lond). 2017; 78 (6): 333-337. https://doi.org/10.12968/hmed.2017.78.6.333

12. Walker MD, Silverberg SJ. Primary hyperparathyroidism. Nat Rev Endocrinol. 2018; 14 (2): 115-125. https://doi.org/10.1038/nrendo.2017.104

13. Insogna KL. Primary hyperparathyroidism. N Eng J Med. 2018; 379 (11): 1050-1059. https://doi.org/10.1056/NEJMcp1714213

14. Fuleihan GE, Arnold A. Pathogenesis and etiology of primary hyperparathyroidism. 2020. Uptodate. Disponible en: https://www-uptodate-com.binasss.idm.oclc.org/contents/pathogenesis-and-etiology-of-primary-hyperparathyroidism?search=pathogenesis%20and%20etiology%20of%20primary%20hyperparathyroidism&source=search_result&selectedTitle=1~120&usage_type=default&display_rank=1

15. Zhu CY, Sturgeon C, Yeh MW. Diagnosis and Management of Primary Hyperparathyroidism. JAMA. 2020; 323 (12): 1186-1187. https://doi.org/10.1001/jama.2020.0538

16. Mc Henry CR, Shi HH. Can parathyroid hyperplasia be predicted preoperatively?. Am J Surg. 2018; 215 (3): 389-392. https://doi.org/10.1016/j.amjsurg.2017.10.051

17. Goswamy J, Lei M, Simo R. Parathyroid carcinoma. Curr Opin Otolaryngol Head Neck Surg. 2016; 24 (2): 155-162. https://doi.org/10.1097/MOO.000000000000023

18. Cetani F, Pardi E, Marcocci C. Parathyroid Carcinoma. From Hom Res. 2019; 51: 63-76. https://doi.org/10.1159/000491039